473 related articles for article (PubMed ID: 28189542)
1. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
López-Fernández T; Thavendiranathan P
Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
[TBL] [Abstract][Full Text] [Related]
2. Advanced imaging modalities to detect cardiotoxicity.
Awadalla M; Hassan MZO; Alvi RM; Neilan TG
Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
[TBL] [Abstract][Full Text] [Related]
3. Early Diagnosis and Prediction of Anticancer Drug-induced Cardiotoxicity: From Cardiac Imaging to "Omics" Technologies.
Madonna R
Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):576-582. PubMed ID: 28246019
[TBL] [Abstract][Full Text] [Related]
4. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
5. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
Garg V; Vorobiof G
Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity due to chemotherapy: role of cardiac imaging.
Poulin F; Thavendiranathan P
Curr Cardiol Rep; 2015 Mar; 17(3):564. PubMed ID: 25648628
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.
Khouri MG; Klein MR; Velazquez EJ; Jones LW
Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
9. Update in imaging of cancer therapy-related cardiac toxicity in adults.
de Baat EC; Naaktgeboren WR; Leiner T; Teske AJ; Habets J; Grotenhuis HB
Open Heart; 2021 Apr; 8(1):. PubMed ID: 33863836
[TBL] [Abstract][Full Text] [Related]
10. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced cardiomyopathy.
Higgins AY; O'Halloran TD; Chang JD
Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
[TBL] [Abstract][Full Text] [Related]
12. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
Moonen M; Oury C; Lancellotti P
Curr Oncol Rep; 2017 Aug; 19(10):63. PubMed ID: 28791609
[TBL] [Abstract][Full Text] [Related]
15. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive diagnosis of chemotherapy related cardiotoxicity.
Gillespie HS; McGann CJ; Wilson BD
Curr Cardiol Rev; 2011 Nov; 7(4):234-44. PubMed ID: 22758624
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity from the cardiologist's perspective.
Caro Codón J; Rosillo Rodríguez SO; López Fernández T
Future Cardiol; 2015 Jul; 11(4):425-32. PubMed ID: 26234492
[TBL] [Abstract][Full Text] [Related]
18. Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.
Ong DS; Scherrer-Crosbie M; Coelho-Filho O; Francis SA; Neilan TG
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):487-97. PubMed ID: 24650314
[TBL] [Abstract][Full Text] [Related]
19. Left Ventricular Dysfunction and Chemotherapeutic Agents.
Clasen SC; Wald JW
Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
[TBL] [Abstract][Full Text] [Related]
20. Identifying cancer patients at risk for cardiotoxicity.
Salvatici M; Sandri MT
Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
